Skip to main content

Axxion S.A.

SEC CIK
0002030181
Latest filing
Aug 14, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Axxion S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
1,605
Value
$797.3K
% of portfolio
0.1%
Quarters held
1
Since Q2 2026
Holdings of VRTX by Axxion S.A., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,605$797.3K0.1%–No prior filingHolders